Company Overview and News

Debt King Drahi builds a cable empire on credit

PARIS: The best description of Patrick Drahi’s business model may be the one he gave last year in a talk at his alma mater. “I bought everything on credit,” he told students at French engineering school Polytechnique. “I didn’t take much risk. It’s the banks that lent everything.”
Upvote Downvote

Cable Billionaire Gets a $58 Billion Debt Reminder - Bloomberg

2017-11-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Magna gibt Ergebnisse für das zweite Quartal bekannt

2017-08-14 prnewswire
- Der verwässerte Ertrag pro Aktie steigt im zweiten Quartal um rekordverdächtige 5 % auf 1,48 USD
Upvote Downvote

Magna annonce ses résultats du deuxième trimestre

2017-08-14 prnewswire
- Bénéfices dilués par action records pour le deuxième trimestre de 1,48 $, en hausse de 5 %
Upvote Downvote

Magna Announces Second Quarter Results

2017-08-11 prnewswire
AURORA, ON, Aug. 11, 2017 /PRNewswire/ - Magna International Inc. (TSX: MG; NYSE: MGA) today reported financial results for the second quarter ended June 30, 2017.
Upvote Downvote

Unified Communication as a Service Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

2017-02-14 prnewswire
LONDON, Feb. 13, 2017 /PRNewswire/ -- Unified Communication as a Service (UCaaS) is an emerging technology that is attracting the interest of enterprises and developer communities. UCaaS is a pre-integrated, permanently updated, standardized, and ready-to-go service, which results in enhanced productivity as it accelerates decision-making and business processes while lowering costs.
Upvote Downvote

How a Jazz Pianist Took a Top Post at Wall Street Hedge Fund - Bloomberg

2017-02-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

NeoPhotonics: Positioned For High Speed Growth

2016-11-12 seekingalpha
Last Friday was a bad day for NeoPhotonics (NYSE:NPTN). The stock fell nearly 23% on an earnings and revenue miss. NeoPhotonics is not widely followed given the fact that it has a market cap of just under $500 million. The company is in the business of providing modules and subsystems for high bandwidth/high-speed networks. It is sitting right in the sweet spot of the most prominent global trend and that is the explosion in the amount of data traffic.
Upvote Downvote

Asian Tech Stock Weekly Review (August 31 - September 6, 2009)

2016-11-03 seekingalpha
• NEC Corp. (OTC:NELTY), Hitachi Ltd. (HIT) and Casio Computer Co. (OTCPK:CSIOY) plan to merge their mobile handset operations. This will create the country's second-largest cellphone maker by shipments after Sharp Corp. (OTCPK:SHCAY). The Japanese cellphone makers aim to boost profitability by consolidating operations to save money in a domestic market nearing saturation. A consolidation of the three players would help lessen their spending on development costs and ride out the tough local market.
Upvote Downvote

Nokia hits three-year low amid declining Networks business

2016-10-27 seekingalpha
Nokia (NYSE:NOK) has tumbled in U.S. trading, down 7.6% and setting a three-year low today, after reporting Q3 earnings that missed on revenues as the company tried to ride out a weak market while holding out for synergies from its Alcatel-Lucent merger.
Upvote Downvote

Nokia sales drop as wireless carriers curb network spending

2016-10-27 themalaymailonline
Nokia and rivals such as Sweden’s Ericsson AB are suffering as wireless carriers limit network expenditures after completing the latest investment cycle. ― Reuters picSTOCKHOLM, Oct 27 — Nokia Oyj reported a 6 per cent decline in sales and warned that waning demand for wireless-network equipment will continue to weigh on revenue this quarter. The stock slumped.
Upvote Downvote

Nokia Tumbles to Loss, Vows to Broaden Product Range - WSJ

2016-10-27 wsj
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit
Upvote Downvote

Nokia Sales Beat Estimates as Carriers Maintain Network Spending - Bloomberg

2016-10-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Ericsson’s Inefficiency Seen Leading to Further Job Reductions - Bloomberg

2016-10-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Fearless Forecast: Nokia Android Phones Are Going To Launch Before 2016 Ends

2016-10-02 seekingalpha
GeekBench’s website revealed that some individuals tested a Nokia D1C Android 7.0 handset on September 30.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...